Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial

Completed · Not applicable

Conditions studied: Respiratory Failure, Respiratory Failure With Hypoxia, Endotracheal Intubation

In brief

Complications are common during endotracheal intubation of critically ill adults. Manual ventilation between induction and intubation ("bag-valve-mask" ventilation) has been proposed as a means of preventing hypoxemia, the most common complication of intubation outside the operating room. Safety and efficacy data, however, are lacking. PreVent is a randomized trial comparing manual ventilation between induction and laryngoscopy to no manual ventilation between induction an laryngoscopy during endotracheal intubation of critically ill adults. The primary efficacy endpoint will be the lowest arterial oxygen saturation. The primary safety endpoints will be the lowest oxygen saturation, highest fraction of inspired oxygen, and highest positive end-expiratory pressure in the 24 hours after the procedure.

Key facts

Study ID
NCT03026322
Run by
Vanderbilt University Medical Center
People needed
401
Starts
2017-03-15
Expected to finish
2018-07-06
Last updated by the study team
2018-09-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.